Author:
Grisanti Salvatore,Amoroso Vito,Buglione Michela,Rosati Anna,Gatta Roberto,Pizzocaro Claudio,Ferrari Vittorio D,Marini Giovanni
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Goode RK, El-Naggar AK: Mucoepidermoid carcinoma. World Health Organization Classification of Tumours: Pathology and Genetics of the Head and Neck Tumours. Edited by: Barnes L, Eveson JW, Reichert P, Sidransky D. 2005, Lyon, France: IARC Press, 219-220.
2. Laurie SA, Licitra L: Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol. 2006, 24: 2673-2678. 10.1200/JCO.2005.05.3025.
3. Agulnik M, Siu LL: An update on the systemic therapy of malignant salivary gland cancers: role of chemotherapy and molecular targeted agents. Curr Med Chem Anticancer Agents. 2004, 4: 543-551. 10.2174/1568011043352641.
4. Gibbons MD, Manne U, Carroll WR, Peters GE, Weiss HL, Grizzle WE: Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands. Laryngoscope. 2001, 111: 1373-1378. 10.1097/00005537-200108000-00011.
5. Herbst RS, Arquette M, Shin DM, Dicke K, Vokes EE, Azarnia N, Hong WK, Kies MS: Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck. J Clin Oncol. 2005, 23: 5578-5587. 10.1200/JCO.2005.07.120.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献